Literature DB >> 2117510

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

T T MacDonald1, P Hutchings, M Y Choy, S Murch, A Cooke.   

Abstract

The spot-ELISA technique has been used to enumerate the frequency of cells secreting tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), isolated from biopsies of normal intestine and from biopsies of children with inflammatory bowel disease. TNF-alpha production was undetectable in six out of 12 biopsies from normal intestine and in the other six biopsies it ranged from 60 to 580 TNF-alpha-secreting cells/10(6) isolated intestinal cells. In contrast, cells isolated from biopsies of children with Crohn's disease (n = 9) all showed elevated frequencies of TNF-alpha-secreting cells (500-12,000 secreting cells/10(6) cells). In ulcerative colitis, four out of eight children had increased production of TNF-alpha and in children with indeterminate colitis two out of three had elevated levels. There was no correlation between plasma TNF-alpha levels and the number of intestinal cells secreting TNF-alpha. In controls and all groups of patients IFN-gamma-secreting cells were uncommon. These results suggest that TNF-alpha is an important mediator of inflammation in the human gut, and, furthermore, may play a role in the growth failure frequently seen in children with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117510      PMCID: PMC1535044          DOI: 10.1111/j.1365-2249.1990.tb03334.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  Immunoregulatory function of lamina propria T cells in Crohn's disease.

Authors:  S P James; C Fiocchi; A S Graeff; W Strober
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

4.  T cell-B cell regulation in the intestinal lamina propria in Crohn's disease.

Authors:  C O Elson; E Machelski; D B Weiserbs
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

5.  Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

Authors:  W S Selby; G Janossy; M Bofill; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.

Authors:  C Fiocchi; K R Youngman; R G Farmer
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

8.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease.

Authors:  R P MacDermott; G S Nash; M J Bertovich; R F Mohrman; I J Kodner; D L Delacroix; J P Vaerman
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

10.  Methane excretion in man--a study of breath, flatus, and faeces.

Authors:  L F McKay; M A Eastwood; W G Brydon
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

View more
  140 in total

1.  Activation of nuclear factor kappaB as a target for anti-inflammatory therapy.

Authors:  S Schreiber
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

2.  Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.

Authors:  J Bauditz; S Wedel; H Lochs
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 3.  Ankylosing spondylitis: introductory comments on its diagnosis and treatment.

Authors:  M A Khan
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

4.  LRRK2 is involved in the IFN-gamma response and host response to pathogens.

Authors:  Agnès Gardet; Yair Benita; Chun Li; Bruce E Sands; Isabel Ballester; Christine Stevens; Joshua R Korzenik; John D Rioux; Mark J Daly; Ramnik J Xavier; Daniel K Podolsky
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

5.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

6.  Portal vein thrombosis in a complicated case of Crohn's disease.

Authors:  A Crowe; N Taffinder; G T Layer; A Irvine; R J Nicholls
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

7.  Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease.

Authors:  A al-Dawoud; I Nakshabendi; A Foulis; A M Mowat
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

8.  The distribution of immunoreactive interferon-gamma-containing cells in normal human tissues.

Authors:  F Brett; A Mowat; M A Farquharson; M McGill; C Hind; J Richmond; D Murray; N U Khan; A K Foulis
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

9.  Comparative tight junction protein expressions in colonic Crohn's disease, ulcerative colitis, and tuberculosis: a new perspective.

Authors:  Prasenjit Das; Pooja Goswami; Tapash K Das; Tapas Nag; Vishnubhatla Sreenivas; Vineet Ahuja; Subrat K Panda; Siddhartha Datta Gupta; Govind K Makharia
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

10.  The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.

Authors:  Matthias Prager; Janine Büttner; Verena Haas; Daniel C Baumgart; Andreas Sturm; Martin Zeitz; Carsten Büning
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.